alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### BELL v LERTZMAN et

Ohio Appeals, 8th Dist, Cuyahoga Co

No. 10461.

Decided January 20, 1930

Mr. A. W. Bell, Esq., Cleveland, for Bell.

Mr. Thomas M. Kennedy, Jr., Cleveland, for Lertzman et.

VICKERY, P. J.

Considerable learning has been expended and much industry shown by counsel *124for the plaintiff, who is himself, and we sympathize with him that he is not able to collect a fee which he probably earned in the first place, but which he surely earned in his efforts to collect the same, but unfortunately none of the cases that he cites are in point. We at once concede that where a contract has been entered into which will result in the earning of money in the future, even though not yet due, it has a potential existence so that it is subject to attachment, and that is as far as any of his cases go. Undoubtedly if in this case, the tenancy having started July first, the rent was not to be paid until the end of July, an attachment during the month of July would reach that money. But that is not the situation here. Each tenant was a tenant from month to month and they owed no money on July 27th, and the tenancy might have terminated, either by the action of the landlord or by their own voluntary action on August first by simply vacating the property, and the only contract that there was, was the contract for the current month after the tenancy had started for that month.

Now before’the new contract of tenancy began on August first the ownership of this property had changed for all practical purposes. It was" no longer in the hands of Lertzman but in the hands of the court through its receiver, and the receiver was directed and ordered to collect these rents; and so whatever the answer might have been of these garnisheed tenants, the fact remained that Lertzman had no interest in this money and could not himself collect it and the attaching creditor could get no better right that the debtor might have had, and the debtor having no right, the attaching creditor surely could not get one; and under the order of the Court of Common Pleas the debtor, the defendant in this action, had no right to this money and, therefore, no matter what the tenants answered, they could not take away the money that was in the possession of the officer of the court, whose duty it was to collect it.

Therefore, we can see no error in the judgment of the court below and the judgment will be affirmed.

Levine, J., concurs. Sullivan, J., not participating.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Drug Enforcement Administration

                    By notice dated February 10, 2000, and published in the                     **Federal Register**                     on February 17, 2000, (65 FR 33), Novartis Pharmaceutical Corporation, 59 Route 10, East Hanover, New Jersey 07926, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of methylphenidate (1724), a basic class of controlled substance listed in Schedule II.                

The firm plans to manufacture finished product for distribution to its customers.

DEA has considered the factors in title 21, United States Code, section 823(a) and determined that the registration of Novartis Pharmaceutical Corporation to manufacture methylphenidate is consistent with the public interest at this time. DEA has investigated Novartis Pharmaceutical Corporation on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic class of controlled substance listed above is granted.

Dated: May 12, 2000.

John H. King,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 00-12841  Filed 5-22-00; 8:45 am]

BILLING CODE 4410-09-M
§ 1960.55 Training of supervisors. ( a ) Each agency shall provide occupational safety and health training for supervisory employees that includes: supervisory responsibility for providing and maintaining safe and healthful working conditions for employees, the agency occupational safety and health program, section 19 of the Act, Executive Order 12196, this part, occupational safety and health standards applicable to the assigned workplaces, agency procedures for reporting hazards, agency procedures for reporting and investigating allegations of reprisal, and agency procedures for the abatement of hazards, as well as other appropriate rules and regulations.
( b ) This supervisory training should include introductory and specialized courses and materials which will enable supervisors to recognize and eliminate, or reduce, occupational safety and health hazards in their working units. Such training shall also include the development of requisite skills in managing the agency's safety and health program within the work unit, including the training and motivation of subordinates toward assuring safe and healthful work practices.
<TABLE> <S> <C>

<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                          41,929
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                              0
<ALLOWANCE>                                          0
<TOTAL-ASSETS>                                 267,417
<DEPOSITS>                                           0
<SHORT-TERM>                                   366,350
<LIABILITIES-OTHER>                             14,127
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           216
<OTHER-SE>                                   (113,276)
<TOTAL-LIABILITIES-AND-EQUITY>                 267,417
<INTEREST-LOAN>                                      0
<INTEREST-INVEST>                               33,569
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                33,569
<INTEREST-DEPOSIT>                                   0
<INTEREST-EXPENSE>                              11,219
<INTEREST-INCOME-NET>                           22,350
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                152,881
<INCOME-PRETAX>                              (130,531)
<INCOME-PRE-EXTRAORDINARY>                   (130,531)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (130,531)
<EPS-BASIC>                                     (6.04)
<EPS-DILUTED>                                   (6.04)
<YIELD-ACTUAL>                                    4.66
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                    0
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
§ 36.300 Admission. ( a ) *General.* No person shall, on the basis of sex, be denied admission, or be subjected to discrimination in admission, by any recipient to which §§ 36.300 through 36.310 apply, except as provided in §§ 36.225 and 36.230.
( b ) *Specific prohibitions.* ( 1 ) In determining whether a person satisfies any policy or criterion for admission, or in making any offer of admission, a recipient to which §§ 36.300 through 36.310 apply shall not: ( i ) Give preference to one person over another on the basis of sex, by ranking applicants separately on such basis, or otherwise;
( ii ) Apply numerical limitations upon the number or proportion of persons of either sex who may be admitted; or
( iii ) Otherwise treat one individual differently from another on the basis of sex.
( 2 ) A recipient shall not administer or operate any test or other criterion for admission that has a disproportionately adverse effect on persons on the basis of sex unless the use of such test or criterion is shown to predict validly success in the education program or activity in question and alternative tests or criteria that do not have such a disproportionately adverse effect are shown to be unavailable.
( c ) *Prohibitions relating to marital or parental status.* In determining whether a person satisfies any policy or criterion for admission, or in making any offer of admission, a recipient to which §§ 36.300 through 36.310 apply: ( 1 ) Shall not apply any rule concerning the actual or potential parental, family, or marital status of a student or applicant that treats persons differently on the basis of sex;
( 2 ) Shall not discriminate against or exclude any person on the basis of pregnancy, childbirth, termination of pregnancy, or recovery therefrom, or establish or follow any rule or practice that so discriminates or excludes;
( 3 ) Subject to § 36.235(d), shall treat disabilities related to pregnancy, childbirth, termination of pregnancy, or recovery therefrom in the same manner and under the same policies as any other temporary disability or physical condition; and
( 4 ) Shall not make pre-admission inquiry as to the marital status of an applicant for admission, including whether such applicant is “Miss” or “Mrs.” A recipient may make pre-admission inquiry as to the sex of an applicant for admission, but only if such inquiry is made equally of such applicants of both sexes and if the results of such inquiry are not used in connection with discrimination prohibited by these Title IX regulations.
§ 35.30 Compliance reviews. ( a ) CRC may conduct such compliance reviews, pre-award reviews, and other similar procedures as permit CRC to investigate and correct violations of the Act and this part, irrespective of whether a complaint has been filed against a recipient. Such reviews may be as comprehensive as necessary to determine whether a violation of the Act or this part has occurred.
( b ) Where a review conducted pursuant to paragraph (a) of this section indicates a violation of the Act or this part, CRC will attempt to achieve voluntary compliance. If voluntary compliance cannot be achieved, CRC will begin enforcement proceedings, as described in § 35.36.
Director
Fee
Arrangements                                                          Exhibit
10.9





Each
non-employee director of Capitol Federal Financial (the "Company") receives an
annual retainer, paid monthly, of $22,000 for his or her service on the board of
directors of Capitol Federal Savings Bank (the "Bank") and $22,000 for his or
her service on the Company's board of directors ($44,000 in total).





John B.
Dicus, Chairman of the Board, President and Chief Executive Officer is paid
$12,000 by the Bank and $12,000 by the Company ($24,000 in total) for his
service as a director of the Bank and Company.
§ 1915.9 Compliance duties owed to each employee. ( a ) *Personal protective equipment.* Standards in this part requiring the employer to provide personal protective equipment (PPE), including respirators and other types of PPE, because of hazards to employees impose a separate compliance duty with respect to each employee covered by the requirement. The employer must provide PPE to each employee required to use the PPE, and each failure to provide PPE to an employee may be considered a separate violation.
( b ) *Training.* Standards in this part requiring training on hazards and related matters, such as standards requiring that employees receive training or that the employer train employees, provide training to employees, or institute or implement a training program, impose a separate compliance duty with respect to each employee covered by the requirement. The employer must train each affected employee in the manner required by the standard, and each failure to train an employee may be considered a separate violation.
[73 FR 75587, Dec. 12, 2008]
§ 413.17 Continuing accuracy of application; supplemental information; amendment. ( a ) An applicant must ensure the continuing accuracy and completeness of information furnished to the FAA as part of a pending license or permit application. If at any time the information an applicant provides is no longer accurate and complete in all material respects, the applicant must submit new or corrected information. As part of this submission, the applicant must recertify the accuracy and completeness of the application under § 413.7. If an applicant does not comply with any of the requirements set forth in this paragraph, the FAA can deny the license or permit application.
( b ) An applicant may amend or supplement a license or permit application at any time before the FAA issues or transfers the license or permit.
( c ) Willful false statements made in any application or document relating to an application, license, or permit are punishable by fine and imprisonment under section 1001 of Title 18, United States Code, and by administrative sanctions in accordance with part 405 of this chapter.
[Doc. No. FAA-2006-24197, 72 FR 17018, Apr. 6, 2007]
Exhibit
32.1











CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








In
connection with the Annual Report of Keystone Consolidated Industries, Inc. (the
Company) on Form 10-K for the period ending December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, David L.
Cheek, President and Chief Executive Officer of the Company and I, Bert E.
Downing, Jr., Vice President, Chief Financial Officer, Corporate Controller and
Treasurer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted
pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:





(1)          The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)          The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.














By:
      /s/  David L.
      Cheek
              David
      L. Cheek
              President
      and Chief Executive Officer
              March
      11, 2010
            By:
       /s/  Bert E. Downing,
      Jr.
              Bert
      E. Downing, Jr.
              Vice
      President, Chief Financial Officer,
              Corporate
      Controller and Treasurer
              March
      11, 2010








Note:  The
certification the registrant furnishes in this exhibit is not deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that Section.  Registration
Statements or other documents filed with the Securities and Exchange Commission
shall not incorporate this exhibit by reference, except as otherwise expressly
stated in such filing.
<PAGE>

                                                                   Exhibit 13

Common Stock Prices

Quarter               1996                  1995
First               $12 1/8-10 3/8       $13 3/8-11 1/2
Second               12 1/2-10 1/2        14 3/8-11 3/4
Third                12 1/2-11            12 1/8-10 7/8
Fourth               13-11 1/8            12-    10 1/4

Dividends Per Common Share

Quarter               1996                  1995
First                 $.10                  $.10
Second                 .10                   .10
Third                  .10                   .10
Fourth                 .10                   .10



Principal Products

Lawter International, Inc. is the world's leading developer and manufacturer 
of specialty polymers that form the backbone of printing ink. We make it 
possible to apply inks and coatings to paper, plastic, metal and other 
surfaces more quickly and accurately, with faster drying, so presses can run 
at higher speeds using inks that require less pigment, produce less waste, 
and offer better performance characteristics such as gloss, brightness, and 
rub or scratch-resistance.

Lawter products include printing ink vehicles, slip additives and resins as 
well as fluorescent pigments, and additives for coatings, adhesives and 
rubber compounding.

Printing ink vehicles are fluid gelled compositions which provide to 
lithographic and letterpress printing inks the ability to carry color onto a 
variety of printing surfaces. They influence quality, gloss, drying speed, 
adhesion, rub resistance and press speed.

Slip additives are used in printing inks to provide additional surface slip 
and rub resistance to the ink film.

Synthetic and hydrocarbon resins are used in the production of adhesives, 
liquid printing inks and printing ink vehicles, rubber compounds, paints and 
various coatings to improve durability, chemical resistance, appearance, 
adhesion and speed of drying.

We develop, produce and market products for ink manufacturers and other 
customers using proprietary technologies and modern manufacturing facilities 
in North America, Europe and the Pacific Rim. Lawter was founded in 1940.
MICHAEL ANTHONY

TRIMUAR

,

Petitioner,

v.

STATE OF FLORIDA

,

Respondent.

___________________________/ IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 16

- 2484

Opinion filed June 23, 2016.

Petition for Writ of Habeas Corpus

-- Original Jurisdiction

.

Michael Anthony Trimuar, pro se , Petitioner.

Pamela Jo Bondi, Attorney General, Tallahassee , for Respondent.

PER CURIAM.

DENIED.

B.L. THOMAS, WETHERELL, and WINSOR, JJ., CONCUR.
Electronically Filed Intermediate Court of Appeals CAAP-14-0000538 05-NOV-2014 09:33 AM
#### § 18.403 Exclusion of relevant evidence on grounds of confusion or waste of time.

Although relevant, evidence may be excluded if its probative value is substantially outweighed by the danger of confusion of issues, or misleading the judge as trier of fact, or by considerations of undue delay, waste of time, or needless presentation of cumulative evidence.
#### § 2705.8 Appeal of an initial adverse Commission determination on correction or amendment of the record.

An individual who disagrees with the refusal of the Executive Director to correct or to amend his or her record may submit a request for a review of such refusal to the Chairman, Federal Mine Safety and Health Review Commission, 1331 Pennsylvania Avenue NW., Suite 520N, Washington, DC 20004-1710. The Chairman will, not later than thirty working days from the date on which the individual requests such review, complete such review and make final determination unless, for good cause shown, the Chairman extends such thirty-day period. If, after his or her review, the Chairman also refuses to correct or to amend the record in accordance with the request, the Individual may file with the Commission a concise statement setting forth the reasons for his or her disagreement with the refusal of the Commission and may seek judicial review of the Chairman's determination under 5 U.S.C. 552a(g)(1)(A).

[49 FR 38542, Oct. 1, 1984, as amended at 67 FR 60863, Sept. 27, 2002; 77 FR 48430, Aug. 14, 2012]
**EXHIBIT
      32.2**




**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Lite King Corporation (the “Company”) on
      Form 10-QSB for the period ended December 31, 2007 as filed with the Securities
      and Exchange Commission on the date hereof (the “Report”), the undersigned, in
      the capacities and on the date indicated below, hereby certifies pursuant to
      18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that to his knowledge:




1.  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




2.  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operation of the Company.





Date:
            February
                13, 2008By:
            /s/
                John T. RuddyName:
            John
                T. RuddyTitle:
            Chief
                Financial Officer





A
      signed
      original of this written statement required by Section 906, or other document
      authentications, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to Lite King Corporation and will be retained
      by Lite King Corporation and furnished to the Securities and Exchange Commission
      or its staff upon request.